Ysonut

Ysonut is an international laboratory specializing in the active science of nutrition. A pioneer in micronutrition and dietetics for 30 years, Ysonut offers two standout brands, Inovance (micronutrition / food supplements) and Protéifine (protein diet). Both brands are renowned for the effectiveness of their high-quality formulations. The Ysonut Group initially developed in France and Spain, and has expanded internationally since the 2000s with operations spanning Europe (Belgium and Portugal) and Latin America (Argentina, Uruguay and Mexico).

Ysonut is an international laboratory specializing in the active science of nutrition, through its two brands: Inovance and Protéifine.

As a pioneer in micronutrition, the Inovance brand relies on solid scientific knowledge to develop effective formulas that provide an optimal response to individual needs throughout life. Inovance accounts for the main part of the Group’s sales, and offers, with more than 90 reference, a wide range of food supplements addressing diverse specific needs (e.g. digestion, slimming, well-being, beauty, sleep, women, etc.). Inovance products are exclusively sold in pharmacies. 

The Protéifine brand offers protein diets with more than 100 references, including snacks and recipes, to meet patients' weight-related objectives and constraints. 

Ysonut has capitalized on its medical expertise and know-how in formulation and R&D, historically relying on doctors (c. 3500) to prescribe its products. Since 2007, Ysonut's range of food supplements has been sold in pharmacies (c. 2000) in France and Spain.

AREV’s strategy focuses on leveraging Ysonut’s medical heritage and formulation expertise to establish a leading position in the food supplements segment in France and Spain. With patients increasingly seeking natural alternatives to pharmaceuticals particularly for managing chronic conditions—Ysonut is well-positioned to provide cutting-edge micronutrition solutions. With AREV's support, Ysonut aims to accelerate growth in existing markets, explore new geographies and pursue targeted acquisitions to strengthen its position in the food supplements segment.

2024

Acquisition date

30 M€

Sales at acquisition date

180 – 200

Employees

AREV I

Fund